Key result
Metabolic derangements and peripheral abnormalities emerge as novel therapeutic targets in heart failure.
Answers are grounded in this paper and cite their sources.
This review highlights the complex pathophysiology of heart failure, emphasizing the myocardium, vasculature, and peripheral mechanisms as emerging therapeutic targets.
Heart failure (HF) is a common but complex clinical syndrome associated with a reduced ability of a heart to pump and/or fill with blood. We now appreciate the more complex picture involving metabolic derangements, changes in foetal gene expression and abnormalities in the periphery as forming part of the HF syndrome. Therapeutic targets include the failing myocardium, the vasculature and peripheral mechanisms. The pathophysiology of HF is currently being intensively investigated, with the identification of new relevant mechanisms, some of them emerging as potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Vidal-Pérez et al. (2019) conducted a review in Heart failure. Heart failure pathophysiology involves complex metabolic derangements and peripheral abnormalities, with the failing myocardium, vasculature, and peripheral mechanisms emerging as therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: